Literature DB >> 15676296

Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins".

Steffen Schlehuber1, Arne Skerra.   

Abstract

Lipocalins are a widespread family of small, robust proteins that typically transport or store biological compounds which are either oflow solubility or are chemically sensitive, including vitamins, steroid hormones, odorants and various secondary metabolites. There are approximately ten different lipocalins in the human body, with the plasma retinol-binding protein being the most well known. Some lipocalins have a pathophysiological role, which opens possibilities for their use in medical applications. Furthermore, lipocalins from blood-sucking insects have evolved as scavengers for mediators of inflammation. As well as using the natural ligand-binding function, lipocalins have also been recruited as scaffolds for the design of artificial binding proteins termed 'anticalins'(R). These novel proteins have potential applications as antidotes, antagonistic protein therapeutics or as target-recognition modules in a new generation of immunotoxins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15676296     DOI: 10.1016/S1359-6446(04)03294-5

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  32 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 3.  Research and development of next generation of antibody-based therapeutics.

Authors:  Jing Li; Zhenping Zhu
Journal:  Acta Pharmacol Sin       Date:  2010-08-09       Impact factor: 6.150

4.  Steered molecular dynamics simulations of ligand-receptor interaction in lipocalins.

Authors:  Janne Kalikka; Jaakko Akola
Journal:  Eur Biophys J       Date:  2010-11-13       Impact factor: 1.733

Review 5.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

Review 6.  [Monoclonal antibodies. Principles, generation, application, and side effects].

Authors:  U Sack; F Emmrich
Journal:  Internist (Berl)       Date:  2008-08       Impact factor: 0.743

Review 7.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

Review 8.  Major urinary protein regulation of chemical communication and nutrient metabolism.

Authors:  Yingjiang Zhou; Liangyou Rui
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

Review 9.  Lipocalin 13 regulation of glucose and lipid metabolism in obesity.

Authors:  Yingjiang Zhou; Liangyou Rui
Journal:  Vitam Horm       Date:  2013       Impact factor: 3.421

10.  A structural basis for the pH-dependent xanthophyll cycle in Arabidopsis thaliana.

Authors:  Pascal Arnoux; Tomas Morosinotto; Giorgia Saga; Roberto Bassi; David Pignol
Journal:  Plant Cell       Date:  2009-07-28       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.